DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading portal core
23 articles
Verge Labs has shifted its center of gravity from AI-powered drug hunting to a more practical neuroscience question: how to identify, earlier, which patients a brain drug is most likely to help.
Kailera's 'triple-G' story sounds like another strike in the obesity-drug race, but for now the missing details matter more than the headline.
Investigational ecopipam reduced relapse risk versus placebo in children and adolescents with Tourette syndrome in a phase III randomized withdrawal study.
AI in pharmaceutical R&D is no longer just a molecule-search tool, but an attempt to turn biology into a design system that still has to pass realityās exam.
Researchers have used light to push chemistry uphill: the creation of tiny, strained housane molecules.
Inside glass formed by the Trinity test, researchers found a crystal phase that shows how a brief nuclear extreme can produce matter outside normal synthetic chemistry.
If solar PV gets cheap enough, CO2 stops being just a waste gas and becomes feedstock for industrial materials that can lock carbon away for good.
Varda Space Industries has signed a deal with United Therapeutics that could turn microgravity into a real production line for drugs.
A new analysis suggests that early type 2 diabetes is not only an insulin story, but also a story of disrupted glucagon signaling and liver metabolism.
A University of South Florida study shows PanPep performs well in the lab but much worse in realistic immune-response scenarios.
Sixian You's team published their counterintuitive finding in Nature Methods on April 28.
Pfizerās 2021 AI-driven process optimization pilot cut small-molecule development time by 20%, yet similar gains for biologics remain unproven.
GATC Health claims its AI-driven in silico multi-omics technique reduces therapeutic development costs.
The KGWAS framework has been upgraded to incorporate contextual information, aiming to improve detection power and provide mechanistic insights.
CVS faces a settlement over manipulated insulin prices, potentially saving Americans $7 billion.
New prototype analyzes thousands of molecules simultaneously.
New blueprint aims to accelerate approvals for rare pediatric gene therapies.
IB101ās defined binding pocket marks a structural advance, but the compound has yet to enter preclinical testing.
BIIB094ās phase 1 trial marks the first time an antisense oligonucleotide has successfully targeted LRRK2 in Parkinsonās patients.
A first-in-class antimalarial drug candidate, MK7602, has demonstrated human tolerance in early clinical studies, though its efficacy remains unproven.
Researchers at the Polytechnic University of Madrid's Institute of Solar Energy have developed ultra-thin silicon cells that can be transferred onto virtually any surface using a hot-pick-up technique.
Japanese researchers have developed the first brain-tissue clearing method that keeps cells alive and firing ā neural signals remain intact as the tissue turns optically transparent.
Science Tokyo has developed boron agents that target ASCT2, a transporter found in aggressive tumors, instead of the standard LAT1 route.
